Results 101 to 110 of about 12,482 (250)

Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire

, 2011
Bruce Crawford1, Richard H Stanford2, Audrey Y Wong3, Anand A Dalal2, Martha S Bayliss11Mapi Values, Boston, MA, USA; 2GlaxoSmithKline, Research Triangle Park, NC, USA; 3BioMedical Insights, San Francisco, CA, USABackground: Patient experience and ...
Wong AY, Dalal AA, Crawford B, Stanford RH, Bayliss MS   +4 more
core  

Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study

Clinical and Translational Allergy, Volume 16, Issue 6, June 2026.
ABSTRACT Background Allergic sensitisation is traditionally viewed as a stable trait despite studies suggesting that it may vary across life‐course. This study aims to provide longitudinal evidence of allergic sensitisation and its associated factors in the general population.
Charmaine J. M. Lim, Abdelrahman Omar, Severin Pötscher, Marie‐Kathrin Breyer, Frits M. E. Franssen, Emiel F. M. Wouters, Robab Breyer‐Kohansal   +6 more
wiley   +1 more source

Is allergic rhinitis related to migraine disability in adults?

, 2019
Migraine is a chronic condition with complex pathophysiology. Although immunologic disturbances have been linked to migraine, only few attempts have been made to assess the possibility of allergic rhinitis as a worsening factor of migraine in adults ...
Gustavo Korssak GONÇALVES (7028048), Arnaldo Carlos PORTO NETO (7028057), Gabriel Augusto TONIN (7028039), Gustavo HIRT (7028054), Ricardo Tobias Sartori GRADASCHI (7028033), Douglas Filipi BIANCHI (7028042), Cassiano Mateus FORCELINI (7028027)   +6 more
core   +1 more source

Evaluating stapokibart in the treatment of seasonal allergic rhinitis

Immunotherapy
Seasonal allergic rhinitis (SAR) is a chronic inflammatory condition primarily mediated by type 2 immune responses, typically triggered by specific pollens. Stapokibart is a humanized monoclonal antibody anti-interleukin-4 receptor α subunit, thereby blocking IL-4 and IL-13 signaling pathways.
Wang, Menglin, Li, Jingyun, Zhang, Luo, Zhang, Yuan   +3 more
openaire   +3 more sources

T Cell O‐GlcNAcylation Increases in Patients With Allergic Rhinitis After the Natural Pollen Season

Clinical &Experimental Allergy, EarlyView.
Eduardo I. Cardenas, Maryam Jafari, Emma Nilsson, Agnetha Karlsson, Marianne Petro, Monika Ezerskyte, Ola Winqvist, Lars Olaf Cardell   +7 more
wiley   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal, Roshanay Ejaz Awan, Hur Abbas, Zahra Sania, Ashna Habib, Syeda Kaneez Sakina, Amina Mahmud, Mohammed Mahmmoud Fadelallah Eljack   +7 more
wiley   +1 more source

Stapokibart (CM310): A review in seasonal allergic rhinitis

American Journal of Otolaryngology
Stapokibart (CM310), a humanized anti-IL-4Rα monoclonal antibody, blocks IL-4/IL-13 signaling for type 2 inflammatory diseases like seasonal allergic rhinitis (SAR), where standard of care often fails.Assess stapokibart's efficacy on the primary endpoint (reflective Total Nasal Symptom Score, rTNSS) and safety as add-on therapy in SoC-inadequate ...
Ping, Xue, Jing, Yan, Jianwei, Li
openaire   +2 more sources

Demographic and Comorbidity Associations With Disease Severity and Bony Dehiscence in AFRS

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 3, June 2026.
ABSTRACT Objective(s) The purpose of this study is to explore and describe possible demographic factors and comorbidities as they relate to disease severity of allergic fungal rhinosinusitis (AFRS) on initial presentation. Methods A retrospective review was conducted on 153 patients with AFRS seen at a tertiary care center. Demographics, comorbidities,
Diana Bigler, Brittany Beisel, Hanna Long, Owen Hallauer, Arjun Bhatt, Ibtisam Mohammad, Stilianos Kountakis   +6 more
wiley   +1 more source

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine

, 2016
Xue Yan Wang,1 Margaret Lim-Jurado,2 Narayanan Prepageran,3 Pongsakorn Tantilipikorn,4 De Yun Wang5 1Department of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2St Luke’s Medical Center,
Wang DY, Tantilipikorn P, Lim-Jurado M, Prepageran N, Wang XY   +4 more
core  

Trends in Asthma‐Rhinitis Allergic Multimorbidity and Polysensitization in China: The CARRAD Study

MedComm, Volume 7, Issue 6, June 2026.
This cross‐sectional study highlights the increasing prevalence of allergic diseases and comorbidities under environmental conditions of rapid modernization in China. Our observations underline the relevance of the allergic comorbidities phenotype at the clinical and public health levels.
Wanjun Wang, Jianhong Wang, Guihua Song, Hua Xie, Rongfei Zhu, Yong He, Jun Tang, Junge Wang, Jinghua Yang, Lili Zhi, Lin Wu, Yan Jiang, Xiaoqin Zhou, Dongming Huang, Ning Wang, Rui Xu, Yuan Gao, Zhimin Chen, Xiaoli Han, Guolin Tan, Jinzhun Wu, Deyu Zhao, Jianjun Chen, Weixi Zhang, Yuemei Sun, Yi Jiang, Weitian Zhang, Qianhui Qiu, Chuanhe Liu, Jie Yin, Guodong Hao, Huabin Li, Yongsheng Xu, Shaohua Chen, Shi Chen, Juan Meng, Dan Zeng, Wei Tang, Chuangli Hao, Nanshan Zhong, Jing Li, the China Alliance of Research on Respiratory Allergic Disease (CARRAD)   +41 more
wiley   +1 more source